Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evogene Ltd EVGN

Healthcare Biotechnology
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.


NDAQ:EVGN - Post by User

Evogene Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Post by whytestockson Feb 26, 2024 7:45pm
37 Views
Post# 35900392

Evogene Schedules Fourth Quarter 2023 Financial Results Rele

Evogene Schedules Fourth Quarter 2023 Financial Results Rele
JUST IN: $EVGN Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024Evogene Schedules Fourth Quarter 2023 Financial Results Release &amp; Conference Call for March 7th, 2024 Evogene Schedules Fourth Quarter 2023 Financial Results Release &amp; Conference Call for March 7th, 2024 PR Newswire Conference call scheduled for 9:00 AM ET ...EVGN - Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities